Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
International Journal of Impotence Research|November 18, 2000
Axial penile rigidity as primary efficacy outcome during multi-institutional in-office dose titration clinical trials with alprostadil alfadex in patients with erectile dysfunction. Alprostadil Alfadex Study GroupI Goldstein, S Auerbach, H Padma-Nathan, et al.
The Journal of Sexual Medicine|January 21, 2006
Erectile dysfunction is a marker for cardiovascular disease: results of the minority health institute expert advisory panelKevin L Billups, Alan J Bank, Harin Padma-Nathan, et al.
International Journal of Impotence Research|August 2, 2002
Long-term safety and efficacy of oral phentolamine mesylate (Vasomax) in men with mild to moderate erectile dysfunctionH Padma-Nathan, I Goldstein, I Klimberg, et al.
Urology|November 5, 2002
A 4-year update on the safety of sildenafil citrate (Viagra)Harin Padma-nathan, Ian Eardley, Robert A Kloner, et al.
Urology|February 2, 2000
Intracavernous alprostadil alfadex is more efficacious, better tolerated, and preferred over intraurethral alprostadil plus optional actis: a comparative, randomized, crossover, multicenter studyR Shabsigh, H Padma-Nathan, M Gittleman, et al.
Journal of Biomechanical Engineering|May 1, 1987
Characterization of penile erectile states using external computer-based monitoringD A Frohrib, I Goldstein, T R Payton, et al.
The Journal of Sexual Medicine|January 21, 2006
Determining the earliest time within 30 minutes to erectogenic effect after tadalafil 10 and 20 mg: a multicenter, randomized, double-blind, placebo-controlled, at-home studyRaymond C Rosen, Harin Padma-Nathan, Ridwan Shabsigh, et al.
International Journal of Impotence Research|January 18, 2008
Erectile dysfunction as a harbinger for increased cardiometabolic riskK L Billups, A J Bank, H Padma-Nathan, et al.
The Journal of Clinical Investigation|February 1, 1993
Oxygen tension regulates the nitric oxide pathway. Physiological role in penile erectionN Kim, Y Vardi, H Padma-Nathan, et al.
International Journal of Impotence Research|August 9, 2001
The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trialH Porst, R Rosen, H Padma-Nathan, et al.
Pageof 6